BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

May 29, 2020

View Archived Issues
Components of the nasal sample kit

FDA clears the way for Letsgetchecked’s at-home COVID-19 test

New York-based at-home testing startup Letsgetchecked said Friday that the U.S. FDA has granted emergency use authorization (EUA) for its COVID-19 Sure-track Test for signs of active SARS-CoV-2 infection. The polymerase chain reaction (PCR) nasal swab test is for use by at-risk individuals in the home and delivers results within 24 hours of a sample being received by the company’s CLIA-certified laboratory. Read More
Components of the self-collection kit

Quest gains EUA for COVID-19 diagnostic self-collection kit

The U.S. FDA granted an emergency use authorization (EUA) for Quest Diagnostics Inc.’s self-collection kit for COVID-19. The kit allows individuals to collect their own specimens at home or in a health care setting. Read More

Inivata reveals collaboration, investment from Neogenomics

LONDON – Neogenomics Laboratories Inc. is to make a $25 million equity investment in Inivata Ltd. and has taken an option to acquire all of the company as part of a U.S. commercialization agreement with the U.K. liquid biopsy specialist. Under the deal, Neogenomics will take over sales, marketing and billing for Inivata’s Invisionfirst circulating tumor DNA lung cancer test, which is intended to replace tissue biopsies. Read More
CMS-medicare-reimbursement.png

NTAP eligibility for Sentinel, Aquabeam devices set to expire for Medicare NTAP program

The Medicare inpatient draft is always an event due to its impact on medical technology. Now, several products soon may see their new technology add-on payments (NTAP) expire because of eligibility. The Centers for Medicare and Medicaid Services (CMS) said both Claret Medical Inc.’s Sentinel embolic protection device and Procept Biorobotics Corp.’s Aquabeam device have used up their NTAP eligibility, and hospitals may see lower rates for using those devices starting Oct. 1 Read More
Carmat’s artificial heart product image

Carmat obtains nod for reimbursement for its total artificial heart under innovation scheme in France

PARIS – Carmat SA, which is based in Vélizy Villacoublay, France, reported the first implantation of its bioprosthetic artificial heart at the Heart Center of the Rigshospitalet in Copenhagen, Denmark. Read More
DNA illustration

Gnomad identifies rare loss of function variants

LONDON – A vast new body of genomics research has identified thousands of rare genetic variants that are predicted to cause loss of function in protein coding genes, providing novel in vivo models of human gene inactivation. Read More

Appointments and advancements for May 29, 2020

New hires and promotions in the med-tech industry, including: Iradimed, Orasure Technologies. Read More

Financings for May 29, 2020

Med-tech firms raising money in public or private financings, including: Digirad, Genetic Technologies, Hamilton Thorne. Read More

In the clinic for May 29, 2020

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biocept, Caris Life Sciences, Creatv Microtech, Foundation Medicine, Hesperos, Myriad, Personalis, Sengine Precision Medicine, Tiziana Life Sciences. Read More

Med-tech gainers and losers for May 26-29, 2020

The top 10 med-tech stock gainers and losers for the week. Read More

Other news to note for May 29, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Astrazeneca, Acupath, Aeec, Eurofins, Genestack, Google Cloud, Ioniq, Labware, Mission Bio, Nano Diagnosix, Orasure, Prolung, Rockland Immunochemicals, SI-Bone, Tangen, Thermo Fisher, Ursure. Read More

Regulatory actions for May 29, 2020

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Baibies, Letsgetchecked. Read More

Regulatory front for May 29, 2020

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Hollingsworth & Vose. Read More

BioWorld MedTech’s Neurology Extra for May 29, 2020

Keeping you up to date on recent developments in neurology, including: Vagus nerve research improves stimulation for chronic pain; Restoring nerve-muscle communication in ALS; Biomarkers may help us understand recovery time after concussion; Study: MS risk 29% higher for people living in urban areas. Read More

BioWorld MedTech Patent Highlights: Week 21

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette. Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for Feb. 10, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing